retatrutide clinical trial us for weight loss: Study shows 30% body weight loss Retatrutide: What It Is &
Description
Phase 2 data showed comparable efficacy, with participants receiving 12 mg losing approximately 24% of baseline body weight over 48 weeks
In adipose tissue, the lipogenic effects of GIP appear to be context-dependent and influenced by insulin availability and metabolic status (35)
Lau T, Schild S, Klos B, Schraml J, Archid R, Stengel A, et al
Incretin mimetics and acute pancreatitis: enemy or innocent bystander
Retatrutide-induced weight loss may raise sex hormone-binding globulin (SHBG) levels, altering the ratio of free to total testosterone
Registration Open: 05/26/2025 - 04/26/2028 User Access Closed: 05/26/2028 Course Instructions Click on the Contents tab to watch the on-demand recording
